EzempiloAmalungiselelo

Isidakamizwa 'Ibuprofen': izinkomba zokusetshenziswa

Isidakamizwa esithi "i-Ibuprofen" sinamakhemikhali e-antipyretic, anti-inflammatory and analgesic, ahlobene nomphumela ku-biosynthesis ye-prostaglandins. Isidakamizwa senzelwe ukusetshenziswa kwangaphakathi, sitholakala ngendlela yamathebulethi (200 milligrams) nokumiswa.

Imishanguzo emva kokukwamukela ixoshwa yizinso ngendlela yama-conjugates, futhi ingxenye yokwakheka okungaguquki. Ukuhlushwa okuphezulu kokusebenza okusebenzayo egazini kwenzeka ngemva kwamahora amathathu emva kokufaka isicelo. Gcina imithi ingenakufinyelela kwezingane ekushiseni okujwayelekile.

Isidakamizwa "Ibuprofen": izinkomba zokusetshenziswa

Umuthi unqunyelwe ukwelashwa kwesifo samathambo, i-osteoarthritis, i-bursitis, i-gout, i-radiculitis. Isidakamizwa sisetshenziselwa ukwelashwa kwe-neuralgia, i-myalgia, i-ankylosing spondylitis, i-adnexitis, ukuvuvukala okubangelwa ukulimala kwezicubu ezithambile, uhlelo lwe-musculoskeletal. Isidakamizwa sisebenza kahle kumazinyo, izinsizwa kanye nezifo ze-ENT.

Isidakamizwa "Ibuprofen": izinkomba zokusetshenziswa kanye nendlela yokuphatha

Isidakamizwa sisetshenziswa kanje.

Lapho amaphilisi e-arthritis e-rheumato athathwa kathathu ngosuku, umthamo owodwa u-800 mg. Nge-spondylitis ene-ankylosing ne-osteoarthritis ibeke u-0.6 g, inani lezincomo - izikhathi ezingu 4 ngosuku. Inani elifanayo lemithi emibili kuya kathathu ngosuku lisetshenziselwa ukwelula imigudu nemisipha, ukuvuvukala kwezicubu ezithambile. Ngesifo esibucayi se-syndrome, isidakamizwa sidakiwe kathathu u-400 mg ngamunye. Umthamo wansuku zonke wezidakamizwa akufanele ube ngaphezu kuka 2.4 amagremu.

Isidakamizwa "Ibuprofen": izinkomba zokusebenzisa ukwelashwa kwezingane

Kuzingane ezingaphezu kweminyaka engu-12 ubudala, isilinganiso sokuqala esingu-0.2 ... 0.3 g sinqunywe kathathu ngosuku. Ngemuva kwemali yansuku zonke yesidakamizwa inqunyelwe ku-0.1 g enenani elilinganayo lamanani. Umthamo omkhulu womuthi akufanele udlule igramu eyodwa.

Ngomuthi we-rheumatoid wezingane, umuthi unikezwa ekubalweni kuka-40 mg ngekhilogremu yesisindo, uhlukaniswe ngezimpendulo eziningana.

Ukuze unciphise izinga lokushisa eliphezulu (39 nangaphezulu), umuthi uthathwa ekubalweni kuka-10 mg ngekhilogremu yesisindo, ekushiseni komzimba okuphansi, umthamo uyingxenye eyodwa.

Ukuze ukwelashwa kwezingane, kunconywa ukuthi usebenzise ukumiswa.

Isidakamizwa "Ibuprofen": izinkomba zokusetshenziswa kanye nemiphumela emibi

Ngenkathi yokwelapha, kungase kube khona ukubonakaliswa okungalungile kusukela ekusebenziseni imithi. Ezinye iziguli zithola ukukhwabanisa, ukuhlanza, isicanucanu, ikhanda, i-anorexia. Ezingxenyeni zesimiso sokugaya ukudla, i-flatulence, isifo sohudo, noma ukuqothulwa kwenzeka. Kwezinye izimo, kuphawulwa ukuphazamiseka kokulala.

Imithelela emibi ingabandakanya nokuhlukunyezwa kwesikhumba, ukulimala, ukukhubazeka okubukwayo kanye nekhala eligijima. Ngezinye izikhathi izilonda ezinomsoco nezilonda zesisu namathumbu, ukuphuma kwegazi, i-aseptic meningitis.

Isidakamizwa "i-Ibuprofen": ukuphikisana

Akunconywa ukuba uthathe isidakamizwa "Ibuprofen" ngesikhathi ukhulelwe, kungenzeka kuphela ngezinhloso zokwelapha. Isidakamizwa siyaphikisana nokubola, isifo sokudla kwesisu, ukuqhuma kwesilonda se-peptic, nge-hematopoiesis ephazamisekile. Kubalulekile ukusebenzisa ngokucophelela ukwelashwa kokuphulwa emsebenzini wezinso nesibindi, izifo zenhliziyo nezisifo.

Ukwamukelwa akuvunyelwe ukuphazamiseka kwemizwa ye-optic, ukungabekezelelani kumzimba wezingxenye zomuthi "Ibuprofen". Lapho ukondla, izingane ezineminyaka engaphansi kweminyaka eyisithupha zingakunqunywa udokotela kuphela, ukuzivocavoca akuvumelekile.

Ezimweni zokudlula ngokweqile, ukuhlanza noma i-nausea kwenzeka, kanye nobuhlungu besisu. Kungase kube nokuvimbela, ukucindezeleka nokulala, kukhona umsindo nobuhlungu ezindlebeni.

Uma kudliwa ngokweqile ukuhlanza isisu ngamanzi, thatha amalahle asebenzayo, bese usebenzisa isiphuzo se-alkaline.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 zu.delachieve.com. Theme powered by WordPress.